• 1
    IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol 59. Hepatitis viruses. Lyon, France: International Agency for Research on Cancer; 1994.
  • 2
    IARC Monograph on the Evaluation of Carcinogenic Risk to Humans, Vol 56. Some naturally occurring substances: Some food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, France: International Agency for Research on Cancer; 1993.
  • 3
    Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD. et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943946.
  • 4
    Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN. et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3: 310.
  • 5
    Harris CC. Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol Biomarkers Prev 1994; 3: 12.
  • 6
    Wild CP, Jansen LAM, Cova L, Montesano R. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ Health Perspect 1993; 99: 115122.
  • 7
    De Flora S, Hietanen E, Bartsch H, Camoirano A, Izzotti A, Bagnasco M, Millman I. Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. Carcinogenesis 1989; 10: 10991106.
  • 8
    Sell S, Hunt JM, Dunsford HA, Chisari FV. Synergy between hepatitis B virus expression and chemical hepatocarcinogenesis in transgenic mice. Cancer Res 1991; 51: 12781285.
  • 9
    Kirby G, Chemin I, Montesano R, Chisari FV, Lang MA, Wild CP. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol Carcinog 1994; 11: 7480.
  • 10
    Ando K, Moriyama T, Guidotti LG, Wirth S, Shreiber RD, Schicht HJ, Huang SN. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 15411554.
  • 11
    Chisari FV, Filippi P, McLachlan A, Milich DR, Riggs M, Lee S, Palmiter RD. et al. Expression of hepatitis B large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol 1986; 60: 880887.
  • 12
    Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA. et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B transgenic mice. Cell 1989; 59: 11451156.
  • 13
    Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the “healthy” HBsAg carrier state. Hepatology 1987; 7: 758763.
  • 14
    Honkakoski P, Lang M. Mouse liver phenobarbital-inducible P450 system: purification, characterization and differential inducibility of four cytochrome P450 isozymes from the D2 mouse. Arch Biochem Biophys 1989; 273: 4257.
  • 15
    Quinn BA, Crane TL, Kocal TE, Best SJ, Cameron RG, Rushmore TH, Farber E. et al. Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1. Toxicol Appl Pharmacol 1990; 105: 351363.
  • 16
    Squires EJ, Negishi M. Reciprocal regulation of sex-dependent expression of testosterone 15α-hydroxylase (p-45015α) in liver and kidney of male mice by androgen. J Biol Chem 1988; 263: 41664171.
  • 17
    Negishi M, Lindberg R, Burkhart B, Ichikawa T, Honkakoski P, Lang MA. Mouse steroid 15α hydroxylase gene family: identification of type II P450 15α as a coumarin hydroxylase. Biochemistry 1989; 28: 41694172.
  • 18
    Omura T, Sato R. The carbon monoxide-binding pigment of liver micro-somes: I. Evidence for its hemoprotein nature. J Biol Chem 1964; 239: 23702378.
  • 19
    Pellinen P, Honkakoski P, Stenback F, Niemitz M, Alhava E, Pelkonen O, Lang MA. et al. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol 1993; 270: 3543.
  • 20
    Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy- and benzyloxyphenoxasones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 1985; 34: 33373345.
  • 21
    Reinke LA, Moyer MJ. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 1985; 13: 548552.
  • 22
    Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 1953; 55: 416421.
  • 23
    Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 71307139.
  • 24
    Nare B, Smith JM, Prichard RK. Induction of glutathione S-transferase isoenzymes in mouse liver by 5-(2-pyrazynl)-4-methyl-1,2-dithiole-3-thione (oltipraz). Biochem Pharmacol 1992; 43: 873879.
  • 25
    Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Clin Med 1967; 70: 158169.
  • 26
    Wolf CR, Moll E, Friedberg T, Oesch F, Buchmann A, Kuhlmann WD, Kunz HW. Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P450, compared with three further P450-isoenzymes, NADPH P450-reductase, glutathione transferases and microsomal epoxide hydrolase. Carcinogenesis 1984; 5: 9931001.
  • 27
    Buchmann A, Bauer-Hoffman R, Mahr J, Drinkwater NR, Luz A, Schwarz M. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc Natl Aca Sci U S A 1991; 88: 911915.
  • 28
    Renton KW, Knickle LC. Regulation of hepatic cytochrome P-450 during infectious disease. Can J Physiol Pharmacol 1990; 68: 777781.
  • 29
    Farrell GC, Cooksley WGE, Powell LW. Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther 1979; 26: 483492.
  • 30
    Stanley LA, Adams DJ, Balkwill FR, Griffin D, Wolf CR. Differential effects of recombinant interferon alpha on constitutive and inducible cytochrome P450 isozymes in mouse liver. Biochem Pharmacol 1991; 42: 311320.
  • 31
    George J, Liddle C, Murray M, Byth K, Farrell GC. Pre-transplantational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem Pharmacol 1995; 49: 873881.
  • 32
    Nerurkar PV, Park SS, Thomas PE, Nims RW, Lubet RA. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochrome P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 1993; 46: 933943.
  • 33
    Hahnemann B, Salonpää P, Pasanen M, Mäenpää J, Honkakoski P, Juvonen R, Lang MA. et al. Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P450 2a-4/5 (Gyp 2a-4/5) expression. Biochem J 1992; 286: 289294.
  • 34
    Spandau DF, Lee CH. Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 1987; 62: 427434.
  • 35
    Zahm P, Hofschneider PH, Koshy R. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 1988; 3: 169177.
  • 36
    Colgrove R, Simon G, Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 1988; 63: 40194026.
  • 37
    Hu KQ, Vierling M, Siddiqui A. Trans-activation of HLA-DR gene by hepatitis B virus Xgene product. Proc Natl Acad Sci U S A 1990; 87: 71407144.
  • 38
    Pellinen P, Stenback F, Rautio A, Pelkonen O, Lang M, Pasanen M. Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases. Naunyn Schmiedebergs Arch Pharmacol 1993; 348: 435443.
  • 39
    Kirby GM, Pelkonen P, Vatanasapt V, Camus A, Wild CP, Lang MA. Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver. Mol Carcinog 1994; 11: 8189.
  • 40
    Warholm M, Jennson H, Tahir MK, Mannervik B. Purification and characterization of three distinct glutathione-S transferases from mouse liver. Biochemistry 1986; 25: 41194125.
  • 41
    Eaton DL, Ramsdell HS, Neal GE. Bio transformation of aflatoxins. In: EatonDL. GroopmanJD. eds. The toxicology of aflatoxins. San Diego: Academic, 1994: 4565.
  • 42
    Aoyama T, Yamano S, Guzelian PS, Gelboin HV, Gonzalez FJ. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc Natl Acad Sci U S A 1990; 87: 47904793.